Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hector Terán-Navarro

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Annals of Translational Medicine|November 9, 2017
Dendritic cell therapy in melanomaCarmen Alvarez-Dominguez, Ricardo Calderón-Gonzalez, Hector Terán-Navarro, et al.
Vaccines|April 3, 2021
Glyceraldehyde-3-phosphate Dehydrogenase Common Peptides of <i>Listeria monocytogenes</i>, <i>Mycobacterium marinum</i> and <i>Streptococcus pneumoniae</i> as Universal VaccinesDavid Salcines-Cuevas, Hector Terán-Navarro, Ricardo Calderón-Gonzalez, et al.
Cancers|May 28, 2022
Gold Glyconanoparticles Combined with 91-99 Peptide of the Bacterial Toxin, Listeriolysin O, Are Efficient Immunotherapies in Experimental Bladder TumorsHector Terán-Navarro, Andrea Zeoli, David Salines-Cuevas, et al.
Oncoimmunology|February 5, 2019
Pre-clinical development of <i>Listeria</i>-based nanovaccines as immunotherapies for solid tumours: insights from melanomaHector Terán-Navarro, Ricardo Calderon-Gonzalez, David Salcines-Cuevas, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Annals of Translational Medicine|November 9, 2017
Dendritic cell therapy in melanomaCarmen Alvarez-Dominguez, Ricardo Calderón-Gonzalez, Hector Terán-Navarro, et al.
Vaccines|April 3, 2021
Glyceraldehyde-3-phosphate Dehydrogenase Common Peptides of <i>Listeria monocytogenes</i>, <i>Mycobacterium marinum</i> and <i>Streptococcus pneumoniae</i> as Universal VaccinesDavid Salcines-Cuevas, Hector Terán-Navarro, Ricardo Calderón-Gonzalez, et al.
Cancers|May 28, 2022
Gold Glyconanoparticles Combined with 91-99 Peptide of the Bacterial Toxin, Listeriolysin O, Are Efficient Immunotherapies in Experimental Bladder TumorsHector Terán-Navarro, Andrea Zeoli, David Salines-Cuevas, et al.
Oncoimmunology|February 5, 2019
Pre-clinical development of <i>Listeria</i>-based nanovaccines as immunotherapies for solid tumours: insights from melanomaHector Terán-Navarro, Ricardo Calderon-Gonzalez, David Salcines-Cuevas, et al.
Pageof 1